In the latest close session, Oscar Health, Inc. (OSCR) was up +1.27% at $31.20. The stock exceeded the S&P 500, which registered a gain of 0.81% for the day. At the same time, the Dow added 0.27%, and the tech-heavy Nasdaq gained 1.3%.
Heading into today, shares of the company had gained 10.63% over the past month, outpacing the Finance sector's gain of 4.07% and the S&P 500's gain of 1.13%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. The company is forecasted to report an EPS of $0.34, showcasing a 138.2% upward movement from the corresponding quarter of the prior year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.83 billion, up 68.58% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.47 per share and a revenue of $18.7 billion, signifying shifts of +127.81% and +59.85%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Oscar Health, Inc. is currently a Zacks Rank #3 (Hold).
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 65.55. This represents a premium compared to its industry average Forward P/E of 9.99.
It's also important to note that OSCR currently trades at a PEG ratio of 2.15. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Insurance - Multi line industry had an average PEG ratio of 1.11.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 169, finds itself in the bottom 32% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oscar Health, Inc. (OSCR): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).